论文部分内容阅读
目的:探讨平阳霉素治疗口腔颌面部血管瘤的临床疗效。方法:将我院收治的60例口腔颌面部血管瘤患者随机分为2组治疗组和对照组各30例,治疗组给予平阳霉素治疗,对照组给予鱼肝油酸钠硬化治疗,比较2组患者的治疗效果。结果:治疗组患者的治愈率为96.67%,对照组患者的治愈率为73.33%,治疗组明显优于对照组,差异具有统计学意义(P<0.05)。结论:平阳霉素治疗口腔颌面部血管瘤的效果好,是一种具有疗程短,安全、简便、经济,不良反应小等优点,值得临床推广应用。
Objective: To investigate the clinical efficacy of pingyangmycin in the treatment of oral and maxillofacial hemangiomas. Methods: Sixty patients with oral and maxillofacial hemangiomas admitted to our hospital were randomly divided into two groups: treatment group (30 cases) and control group (30 cases). Patients in the treatment group were treated with pingyangmycin Patient’s therapeutic effect. Results: The cure rate of the treatment group was 96.67%, while the cure rate of the control group was 73.33%. The treatment group was significantly better than the control group, the difference was statistically significant (P <0.05). Conclusion: Pingyangmycin is effective in treatment of oral and maxillofacial hemangiomas. It has the advantages of short duration of treatment, safety, simplicity, economy, low adverse reaction, and is worthy of clinical application.